The year 2026 is seeing a massive expansion of India’s pharmaceutical infrastructure as ten new high-tech manufacturing corridors begin operations to meet global demand for injectable medicines. This growth is a direct result of the central government’s latest health policy incentives, which aim to solidify the nation’s role as the primary provider of affordable sterile...